|Articles|December 1, 2002

December 2002
Volume 8
Issue 12

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

Author(s)Jeff Luck, MBA, PhD, John W. Peabody, MD, PhD

Download PDF: When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

Articles in this issue

over 23 years ago

Article

How Effectively Do Managed Care Organizations Influence Prescribing and Dispensing Decisions?

over 23 years ago

Article

Characteristics of Eye Care Practices With Managed Care Contracts

over 23 years ago

Article

Enhancing the Quality of Care for Patients With Coronary Heart Disease: The Design and Baseline Results of the Hastening the Effective Application of Research Through Technology (HEART) Trail

over 23 years ago

Article

Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

over 23 years ago

Article

Profiling Resource Use: Do Different Outcomes Affect Assessments of Provider Efficiency?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues

Female Newborns More Likely to Miss Vitamin K Prophylaxis, Hepatitis B Birth Dose

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease

Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

NYC Legionnaires Disease Cluster Slows as Cooling Tower Remediation Continues

Female Newborns More Likely to Miss Vitamin K Prophylaxis, Hepatitis B Birth Dose

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

FDA Approved At-Home SC Lecanemab Initiation Dose for Early Alzheimer Disease

Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?